HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 257 filers reported holding HERBALIFE LTD in Q4 2020. The put-call ratio across all filers is 2.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $145 | -37.8% | 10,988 | -24.0% | 0.00% | -50.0% |
Q1 2023 | $233 | -53.6% | 14,467 | -57.1% | 0.00% | -50.0% |
Q4 2022 | $502 | -99.9% | 33,707 | -18.4% | 0.00% | -33.3% |
Q3 2022 | $822,000 | -68.0% | 41,305 | -67.2% | 0.01% | -64.7% |
Q2 2022 | $2,572,000 | +328.7% | 125,756 | +536.2% | 0.02% | +466.7% |
Q1 2022 | $600,000 | -22.1% | 19,767 | +5.1% | 0.00% | 0.0% |
Q4 2021 | $770,000 | +12.2% | 18,809 | +16.2% | 0.00% | -25.0% |
Q3 2021 | $686,000 | +1.5% | 16,187 | +26.2% | 0.00% | 0.0% |
Q2 2021 | $676,000 | +40.0% | 12,822 | +17.8% | 0.00% | +33.3% |
Q1 2021 | $483,000 | +13.1% | 10,889 | +22.4% | 0.00% | 0.0% |
Q4 2020 | $427,000 | -83.9% | 8,896 | -84.3% | 0.00% | -82.4% |
Q3 2020 | $2,647,000 | -13.0% | 56,737 | -16.2% | 0.02% | -32.0% |
Q2 2020 | $3,044,000 | +310.2% | 67,682 | +397.7% | 0.02% | +400.0% |
Q3 2018 | $742,000 | -40.4% | 13,600 | -41.4% | 0.01% | -37.5% |
Q2 2018 | $1,246,000 | -5.2% | 23,198 | +71.9% | 0.01% | -11.1% |
Q1 2018 | $1,315,000 | -7.9% | 13,496 | -36.0% | 0.01% | -10.0% |
Q4 2017 | $1,428,000 | +265.2% | 21,092 | +265.7% | 0.01% | +400.0% |
Q3 2017 | $391,000 | -1.8% | 5,768 | +3.4% | 0.00% | -33.3% |
Q2 2017 | $398,000 | +22.8% | 5,580 | 0.0% | 0.00% | +50.0% |
Q1 2017 | $324,000 | +20.4% | 5,580 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $269,000 | -41.8% | 5,580 | -25.2% | 0.00% | -33.3% |
Q3 2016 | $462,000 | -19.8% | 7,460 | -24.2% | 0.00% | -25.0% |
Q2 2016 | $576,000 | +9.7% | 9,845 | +15.3% | 0.00% | 0.0% |
Q1 2016 | $525,000 | +54.4% | 8,536 | +34.7% | 0.00% | +100.0% |
Q4 2015 | $340,000 | -26.7% | 6,339 | -25.5% | 0.00% | -50.0% |
Q3 2015 | $464,000 | +217.8% | 8,508 | +220.7% | 0.00% | +300.0% |
Q2 2015 | $146,000 | +64.0% | 2,653 | +27.1% | 0.00% | 0.0% |
Q1 2015 | $89,000 | +12.7% | 2,087 | +0.1% | 0.00% | 0.0% |
Q4 2014 | $79,000 | -93.3% | 2,085 | -92.3% | 0.00% | -90.0% |
Q3 2014 | $1,181,000 | -13.7% | 26,986 | +27.4% | 0.01% | -9.1% |
Q2 2014 | $1,368,000 | +8.5% | 21,189 | -3.8% | 0.01% | 0.0% |
Q1 2014 | $1,261,000 | -66.8% | 22,023 | -54.4% | 0.01% | -66.7% |
Q4 2013 | $3,803,000 | +2.9% | 48,327 | -8.8% | 0.03% | +3.1% |
Q3 2013 | $3,695,000 | -78.6% | 52,964 | -86.1% | 0.03% | -79.6% |
Q2 2013 | $17,238,000 | – | 381,888 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |